Sign in
RBSH Stock Price, Chart, Stats & News
Rebus Holdings, Inc.
Save
Rebus Holdings, Inc. (RBSH) does not currently pay a dividend.
3,213
Market cap
–
Current P/E
–
Forward P/E
RBSH chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Biotechnology
Industry
Rebus Holdings, Inc. is dedicated to pioneering highly targeted therapies for oncology. Its flagship investigational product, RT-AR001, operates as an adenosine receptor antagonist. This compound, when administered directly into cancerous growths, is engineered to diminish tumor invasion and improve therapeutic efficacy.
Similar securities
Based on sector and market capitalization
Report issue